In June 2023, RANZCP launched a clinical memorandum “Therapeutic Usage of copyright Substances”. The objective of the memo was to inform psychiatrists about the potential therapeutic utilization of copyright substances to aid the treatment of mental illness. Whilst psilocybin mushroom